M
Masashi Mizokami
Researcher at Nagoya City University
Publications - 684
Citations - 37168
Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.
Papers
More filters
Journal ArticleDOI
Virological and Clinical Characteristics of Hepatitis B Virus Genotype A
TL;DR: The virological and clinical characteristics of HBV genotype A will be useful in elucidating the association among persistent viral infection, host genetic factors, and treatment in future studies.
Journal ArticleDOI
Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
Jun Muto,Masaya Sugiyama,Ken Shirabe,Motokazu Mukaide,Ikue Kirikae-Muto,Toru Ikegami,Tomoharu Yoshizumi,Yo-ichi Yamashita,Yoshihiko Maehara,Masashi Mizokami +9 more
TL;DR: There was no correlation between OBI and anti-HBV antibodies, but fewer patients with OBI had high inflammatory activity, suggesting that factors other than inflammation may be involved in HCC carcinogenesis in patients withOBI.
Journal ArticleDOI
Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
Yasuhiro Satoh,Keisuke Hino,Takanobu Kato,Masashi Mizokami,Satoyoshi Yamashita,Hiroki Nakamura,Kiwamu Okita +6 more
TL;DR: Whether particular hepatitis C virus subtypes are spreading among injecting drug users in Yamaguchi prefecture, on the south‐western tip of the island of Honshu in Japan, as found in European countries is examined.
Journal ArticleDOI
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C.
Regino P. Gonzalez-Peralta,Jane W. S. Fang,Gary L. Davis,Robert G. Gish,Michinori Kohara,Mario U. Mondelli,Mickey S. Urdea,Masashi Mizokami,Johnson Y.N. Lau +8 more
TL;DR: It is concluded that hepatic expression of HCV core and NS4 antigens parallels serum HCV-RNA levels and IFN therapy reduces hepaticexpression of these viral antigen.
Journal ArticleDOI
Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
Takeshi Kurihara,Takeshi Kurihara,Takasuke Fukuhara,Chikako Ono,Satomi Yamamoto,Satomi Yamamoto,Kentaro Uemura,Toru Okamoto,Masaya Sugiyama,Daisuke Motooka,Shota Nakamura,Masato Ikawa,Masashi Mizokami,Yoshihiko Maehara,Yoshiharu Matsuura +14 more
TL;DR: The possible use of nickase-Cas9 and d- Cas9 with a pair of sgRNAs for eliminating HBV DNA from the livers of chronic hepatitis B patients with low risk of undesirable off-target mutation on the host genome is suggested.